Sukumar Nagendran
President and Head of R&D
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development and Director | $608,166 | $2,092,890 |
| 2024 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $584,775 | $3,601,660 |
| 2023 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $565,000 | $1,248,120 |
| 2022 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $23,542 | $1,363,545 |
Executive changes
Earnings-call appearances
-
Taysha Gene Therapies Second Quarter 2026 Financial Results Conference Call2026-08-11
Taysha Gene Therapies, Inc. (TSHA)
-
TSHA-102 Rett Syndrome Program Update Conference Call2026-06-22
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2026 Earnings Call2026-05-06
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2025 Earnings Call2026-03-19
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2025 Earnings Call2025-11-04
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2025 Earnings Call2025-08-12
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2025 Earnings Call2025-05-15
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2024 Earnings Call2025-02-26
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2024 Earnings Call2024-11-13
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2024 Earnings Call2024-08-12
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2024 Earnings Call2024-06-26
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2023 Earnings Call2024-03-19
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2023 Earnings Call2023-11-14
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2023 Earnings Call2023-08-14
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2023 Earnings Call2023-05-15
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2022 Earnings Call2023-03-28
Taysha Gene Therapies, Inc. (TSHA)